Dear Shannon
RESAPP HEALTH LIMITED – VOLUNTARY SUSPENSION REQUEST
Further to the request on 22 October 2018 for the securities of ResApp Health Limited (“Company”
to be placed in trading halt, the Company hereby requests that the securities be placed in voluntary suspension in accordance with ASX Listing Rule 17.2 pending release of an announcement regarding its US SMARTCOUGH-C-2 study results and analysis.
The Company requests that the voluntary suspension end on the date the anticipated announcement referred to above is released to the market which the Company anticipates will occur by Monday 29 October 2018.
The Company is not aware of any reason why the voluntary suspension should not be granted, or of any other information necessary to inform the market about the suspension.
